ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
83 906,09
-0,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. HCW Biologics Inc (HCWB)

  7. HCW Biologics Inc (HCWB) Actualités

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HCWB
DateHeureSourceTitreSymboleSociété
06/03/202513h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
06/03/202512h55GlobeNewswire Inc.HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing RequirementsNASDAQ:HCWBHCW Biologics Inc
21/02/202523h29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HCWBHCW Biologics Inc
11/02/202522h54Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:HCWBHCW Biologics Inc
03/02/202513h15GlobeNewswire Inc.HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical TrialNASDAQ:HCWBHCW Biologics Inc
15/01/202513h00GlobeNewswire Inc.HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025NASDAQ:HCWBHCW Biologics Inc
23/12/202414h10GlobeNewswire Inc.HCW Biologics Inc. Received NASDAQ Staff Determination LetterNASDAQ:HCWBHCW Biologics Inc
05/12/202422h37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCWBHCW Biologics Inc
22/11/202422h53Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:HCWBHCW Biologics Inc
20/11/202418h54Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:HCWBHCW Biologics Inc
19/11/202403h27GlobeNewswire Inc.HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ RulesNASDAQ:HCWBHCW Biologics Inc
18/11/202413h00GlobeNewswire Inc.HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product CandidateNASDAQ:HCWBHCW Biologics Inc
14/11/202423h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
14/11/202422h40GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
23/08/202422h35Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HCWBHCW Biologics Inc
23/08/202422h30GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - CorrectionNASDAQ:HCWBHCW Biologics Inc
14/08/202422h35GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
17/06/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
20/05/202422h36Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:HCWBHCW Biologics Inc
15/05/202422h39GlobeNewswire Inc.HCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
15/05/202422h35Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HCWBHCW Biologics Inc
01/04/202422h10GlobeNewswire Inc.HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsNASDAQ:HCWBHCW Biologics Inc
14/11/202313h00GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
08/11/202313h30GlobeNewswire Inc.Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNASDAQ:HCWBHCW Biologics Inc
01/11/202312h30GlobeNewswire Inc.Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual MeetingNASDAQ:HCWBHCW Biologics Inc
06/09/202313h30GlobeNewswire Inc.HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023NASDAQ:HCWBHCW Biologics Inc
11/08/202313h00GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
10/08/202323h01Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:HCWBHCW Biologics Inc
15/06/202323h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HCWBHCW Biologics Inc
14/06/202323h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCWBHCW Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:HCWB

Dernières Valeurs Consultées

NASDAQ
MAYS
J W Mays
USOTC
VTXXF
Vertex Minerals (GM)
BIT
F26606
Vontobel Financial Produ...
COIN
HPLUST
HappyLand.Finance
USOTC
AGRDF
Minnova (PK)
TG
A3K87Z
OP Corporate Bank
BIT
UB3RQG
Unicredit Bank
AMEX
SMOT
VanEck Morningstar SMID ...
USOTC
AFLYY
Air France ADS (PK)
USOTC
BMXC
Bemax (PK)
NASDAQ
HURA
TuHURA Biosciences
COIN
ARWWUST
Arowana Token
NASDAQ
BMEA
Biomea Fusion
FTSE
WIFIN
FTSE Finland
BIT
UB4H0G
Unicredit Bank
DOWI
DJUSPC
DJ US Waste and Disposal...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces